Related Experiment Video
Updated: Aug 5, 2026
09:31
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Multimodality treatment of diffuse malignant pleural mesothelioma
Lambros S Zellos1, David J Sugarbaker
1Department of Surgery, Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA.
Seminars in Oncology
|February 12, 2002
Summary
Diffuse malignant pleural mesothelioma (DMPM) treatment remains complex. Multimodality therapies combining surgery, radiation, chemotherapy, or immunotherapy show promise but require further study due to a lack of comparative trials.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Background:
- Diffuse malignant pleural mesothelioma (DMPM) presents significant diagnostic and therapeutic challenges.
- Historically, single-modality treatments have proven largely ineffective in altering DMPM's natural course.
- The complexity necessitates exploring advanced therapeutic strategies.
Purpose of the Study:
- To review the current landscape of DMPM treatment approaches.
- To evaluate the role of multimodality regimens in managing DMPM.
- To highlight the ongoing debate regarding optimal treatment strategies.
Main Methods:
- Review of existing literature on DMPM treatment.
- Analysis of single-modality versus multimodality therapeutic strategies.
- Discussion of challenges in comparing different treatment regimens.
Main Results:
- Single-modality therapy has limited efficacy for DMPM.
- Multimodality regimens, including surgery, radiation, chemotherapy, and immunotherapy, are being investigated.
- Evidence from randomized controlled trials comparing these strategies is scarce.
Conclusions:
- Multimodality treatment is increasingly considered for DMPM.
- Further high-quality research, particularly randomized controlled studies, is essential to determine the most effective treatment approaches for DMPM.
- The optimal therapeutic strategy for DMPM remains an area of active investigation and debate.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are: